A clinical trial of liver SPIO-MRI in the diagnosis of nonalcoholic steatohepatitis
Not Applicable
- Conditions
- onalcoholic steatohepatitis
- Registration Number
- JPRN-UMIN000000788
- Lead Sponsor
- Division of Gastroenterolgy and Hepatology, Department of Internal Medicine, Keio University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
The patients who have no normal judgement ability for infomed consent. The patients who have past history of allergy to Resovist, contrast agent for liver SPIO-MRI, or kind medicine. The patients who are pregnant or will doublfully be pregnant. The patients who the treating doctors decide are inadequate to enrollment to this trial.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method iver imaging in SPIO-MRI
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
How does SPIO-MRI detect hepatic inflammation and fibrosis in NASH patients compared to other imaging techniques?
What is the diagnostic accuracy of SPIO-MRI versus liver biopsy in NASH staging?
Which non-invasive biomarkers correlate with SPIO-MRI findings in NASH progression?
What are the known adverse events of SPIO-MRI in NASH diagnosis and how are they managed?
How does SPIO-MRI compare to other MRI contrast agents in NASH diagnostic accuracy?